Blocking a key inflammatory pathway improves liver structure and vascular function in cirrhosis, study finds
by Ángeles Gallar,Miguel Hernandez University of ElcheAntagonizing epigenetically controlled PAF/PAF-R pathway improves liver function during experimental cirrhosis. Credit: Universidad Miguel Hernánd
Updated on: December 25,2025
Blocking a key inflammatory pathway improves liver structure and vascular function in cirrhosis, study finds
by Ángeles Gallar,Miguel Hernandez University of ElcheAntagonizing epigenetically controlled PAF/PAF-R pathway improves liver function during experimental cirrhosis. Credit: Universidad Miguel Hernánd
Updated on:December 25,2025
